Dr Reddy’s launches Bosutinib Tablets 400mg, a generic of Bosulif, in the US with MSN Laboratories, holds exclusive US marketing rights, shares down 0.24 percent Friday
Dr Reddy’s launches Bosutinib Tablets 400mg, a generic of Bosulif, in the US with MSN Laboratories, holds exclusive US marketing rights, shares down 0.24 percent Friday